Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kathrina Marcelo-Lewis"'
Autor:
Curtis R. Pickering, Jeffrey N. Myers, Gordon B. Mills, Funda Meric-Berstam, J. Jack Lee, Maura Gillison, Lawrence Ginsberg, Jing Wang, Kathrina Marcelo-Lewis, Kaye Wilson, Lei Feng, Jiexin Zhang, Jeff Lewis, Diana Bell, Faye M. Johnson, Charles Lu, George Blumenschein, Merrill Kies, Robyn Du, Yun Qing, M. Laura Rubin, Frederico O. Gleber-Netto, Xiuning Le
Purpose:Neoadjuvant chemotherapy prior to definitive surgery has been used widely for locally advanced oral squamous cell carcinoma (OSCC). We evaluated neoadjuvant erlotinib with platinum-docetaxel versus placebo with platinum-docetaxel in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f657a47d94546edc7cf435ae88e1938
https://doi.org/10.1158/1078-0432.c.6532335.v1
https://doi.org/10.1158/1078-0432.c.6532335.v1
Autor:
Curtis R. Pickering, Jeffrey N. Myers, Gordon B. Mills, Funda Meric-Berstam, J. Jack Lee, Maura Gillison, Lawrence Ginsberg, Jing Wang, Kathrina Marcelo-Lewis, Kaye Wilson, Lei Feng, Jiexin Zhang, Jeff Lewis, Diana Bell, Faye M. Johnson, Charles Lu, George Blumenschein, Merrill Kies, Robyn Du, Yun Qing, M. Laura Rubin, Frederico O. Gleber-Netto, Xiuning Le
Supplementary Figure from Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7d976fef0b641da5d6fbdf06a9afd5
https://doi.org/10.1158/1078-0432.22486515.v1
https://doi.org/10.1158/1078-0432.22486515.v1
Autor:
Curtis R. Pickering, Jeffrey N. Myers, Gordon B. Mills, Funda Meric-Berstam, J. Jack Lee, Maura Gillison, Lawrence Ginsberg, Jing Wang, Kathrina Marcelo-Lewis, Kaye Wilson, Lei Feng, Jiexin Zhang, Jeff Lewis, Diana Bell, Faye M. Johnson, Charles Lu, George Blumenschein, Merrill Kies, Robyn Du, Yun Qing, M. Laura Rubin, Frederico O. Gleber-Netto, Xiuning Le
Supplementary Data from Induction Chemotherapy with or without Erlotinib in Patients with Head and Neck Squamous Cell Carcinoma Amenable for Surgical Resection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e8a4d3a9ff0b7caa8196df7d652449
https://doi.org/10.1158/1078-0432.22486518
https://doi.org/10.1158/1078-0432.22486518
Autor:
Xiuning Le, Frederico O. Gleber-Netto, M. Laura. Rubin, Yun Qing, Robyn Du, Merrill Kies, George Blumenschein, Jr, Charles Lu, Faye M. Johnson, Diana Bell, Jeff Lewis, Jiexin Zhang, Lei Feng, Kaye Wilson, Kathrina Marcelo-Lewis, Jing Wang, Lawrence Ginsberg, Maura Gillison, J. Jack. Lee, Funda Meric-Bernstam, Gordon B. Mills, William N. William, Jeffrey N. Myers, Curtis R. Pickering
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Purpose: Neoadjuvant chemotherapy prior to definitive surgery has been utilized widely for locally advanced oral squamous cell carcinoma (OSCC). We evaluated neoadjuvant erlotinib with platinum-docetaxel vs. placebo with platinum-docetaxel in stage I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a40b2d2a5c0b7b263620c189e191748b
https://pubmed.ncbi.nlm.nih.gov/35443062
https://pubmed.ncbi.nlm.nih.gov/35443062
